(6aR,9R)-5-bromo-N-[(2S,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide ((2?S)-2-bromo-?-ergocryptine)
Bromocriptine Impurity F is a fully characterized chemical compound used as a reference standard of API Bromocriptine. The standard offered is compliant with regulatory guidelines. Bromocriptine Impurity F is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 82773-21-5
